1. Home
  2. IZEA vs SER Comparison

IZEA vs SER Comparison

Compare IZEA & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IZEA Worldwide Inc.

IZEA

IZEA Worldwide Inc.

N/A

Current Price

$3.69

Market Cap

60.5M

ML Signal

N/A

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

N/A

Current Price

$1.51

Market Cap

19.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IZEA
SER
Founded
2006
2017
Country
United States
United States
Employees
N/A
13
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.5M
19.4M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
IZEA
SER
Price
$3.69
$1.51
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.00
AVG Volume (30 Days)
55.8K
88.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.07
N/A
Revenue
$20,099,695.00
N/A
Revenue This Year
N/A
$134.46
Revenue Next Year
$15.91
N/A
P/E Ratio
$53.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.68
$1.47
52 Week High
$5.86
$7.92

Technical Indicators

Market Signals
Indicator
IZEA
SER
Relative Strength Index (RSI) 51.12 34.98
Support Level $3.48 N/A
Resistance Level $3.85 $1.86
Average True Range (ATR) 0.17 0.12
MACD 0.04 0.02
Stochastic Oscillator 59.09 7.69

Price Performance

Historical Comparison
IZEA
SER

About IZEA IZEA Worldwide Inc.

IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Share on Social Networks: